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Abstract
Mammalian	bombesin	(Bn)	receptors	comprise	3	subtypes:	BB1,	BB2,	BB3	(nomenclature
recommended	by	the	NC-IUPHAR	Subcommittee	on	bombesin	receptors,	[115]).	BB1	and	BB2
are	activated	by	the	endogenous	ligands	neuromedin	B	(NMB),	gastrin-releasing	peptide	(GRP),	and
GRP-(18-27).	bombesin	is	a	tetra-decapeptide,	originally	derived	from	amphibians.	The	three	Bn
receptor	subtypes	couple	primarily	to	the	Gq/11	and	G12/13	family	of	G	proteins	[115].	Each	of	these
receptors	is	widely	distributed	in	the	CNS	and	peripheral	tissues	[78,	115,	249,	278,	237,	362].
Activation	of	BB1	and	BB2	receptors	causes	a	wide	range	of	physiological/pathophysiogical	actions,
including	the	stimulation	of	normal	and	neoplastic	tissue	growth,	smooth-muscle	contraction,
gastrointestinal	motility,	feeding	behavior,	secretion	and	many	central	nervous	system	effects
including	regulation	of	circadian	rhythm,	body	temperature	control,	sighing	and	mediation	of
pruritus	[149,	202,	244,	115,	196,	249,	306,	68,	34,	332].	A	physiological	role	for	the	BB3	receptor
has	yet	to	be	fully	defined	although	recently	studies	suggest	an	important	role	in	glucose	and	insulin
regulation,	metabolic	homeostasis,	feeding,	regulation	of	body	temperature,	obesity,	diabetes
mellitus	and	growth	of	normal/neoplastic	tissues	[148,	78,	162,	214,	346,	200].	Bn	receptors	are	one
of	the	most	frequently	overexpressed	receptors	in	cancers	and	are	receiving	increased	attention	for
their	roles	in	tumor	growth,	as	well	as	for	tumour	imaging	and	for	receptor	targeted	cytotoxicity
[202,	276,	8,	161].
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